NCT06203600 2026-04-17Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialNational Cancer Institute (NCI)Phase 2/3 Recruiting224 enrolled
NCT02135042 2026-04-03Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNANRG OncologyPhase 2/3 Active not recruiting685 enrolled